RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
RXDX
Delisted
RXDX was delisted on the 15th of June, 2023.
103 hedge funds and large institutions have $1.04B invested in Prometheus Biosciences, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 27 increasing their positions, 30 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
10% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 30
Holders
103
Holding in Top 10
4
Calls
$5.38M
Puts
–
Top Buyers
| 1 | +$64.7M | |
| 2 | +$20.6M | |
| 3 | +$10.7M | |
| 4 |
Goldman Sachs
New York
|
+$9.8M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$9.32M |
Top Sellers
| 1 | -$27.6M | |
| 2 | -$19.3M | |
| 3 | -$19.1M | |
| 4 |
O
OrbiMed
New York
|
-$9.88M |
| 5 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$7.91M |